Cyclerion Therapeutics Inc Sustainability Reports
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing treatments for serious neurodegenerative and neuropsychiatric diseases. The company leverages soluble guanylate cyclase (sGC) pharmacology to advance its targeted asset pipeline.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00KXXHZ46
1 reports from 2020 to 2020
Company Profile
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing treatments for serious neurodegenerative and neuropsychiatric diseases. The company leverages soluble guanylate cyclase (sGC) pharmacology to advance its targeted asset pipeline.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
